Media center

Meitar represented TASE-listed Evogene, a plant genomics company, in its $73.8 million initial public offering on the NYSE.

Meitar represented Anobit Israeli semiconductor startup in its acquisition by a multinational corporation.

Our firm, together with US-based Fenwick & West LLP, represented Facebook, Inc. (NASDAQ: FB) in the acquisition of Face.com, the developer of a leading face-recognition technology. Financial terms of the transaction were not disclosed.

Meitar represented privately-held Surpass Medical Ltd., a developer of next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system in its acquisition by Stryker Corporation for up to $135 million, in an all cash transaction.

As part of the transaction, the controlling shareholder purchased the shares of Hot, Israel’s leading cable television company, held by the public in a reverse triangular merger. The controlling shareholder financed the purchase through the issuance of bonds to a syndicate of international banks. These transactions were the last part of the establishment of a leading telecom group in Israel, after purchasing the cellular carrier HOT Mobile (formerly Mirs) from Motorola, and gradually increasing the holdings of the controlling shareholders in HOT over the last three years. The total transaction value, including other share purchases by the controlling shareholder, was $1.1 billion.

Meitar represented UBS and Barclays Capital as underwriters of the $500 million global notes offering by Israel Electric Company.

Meitar represented UBS, Barclays Capital and Citigroup as underwriters of the $1.5 billion global notes offering by the State of Israel.